44
Participants
Start Date
November 30, 2002
Primary Completion Date
March 31, 2007
Study Completion Date
March 31, 2007
L-carnitine
A study drug, L-carnitine, titrating the doses from 0.5 g to 3 g to reduce the possibility of side effects, lasting for two weeeks followed by an extension phase where all patients recieved L-carnitine for an additional two weeks.
Placebo
A placebo, where patients underwent the dose titration identical to the study patients, lasting for two weeeks followed by an extension phase where all patients recieved L-carnitine for an additional two weeks.
Department of Pain Medicine and Palliative Care; Beth Israel Medical Center; First Avenue at 16th Street, New York
National Institute of Nursing Research (NINR)
NIH